20 results
8-K
SYRS
Syros Pharmaceuticals Inc.
18 Dec 19
Entry into a Material Definitive Agreement
7:16am
of the Research Term. GBT’s exercise of the Option will be subject to any required filings with the applicable antitrust authority as required … by the antitrust laws and satisfaction of any applicable antitrust conditions.
Exclusivity. From the date of the Collaboration Agreement until the end
8-K
EX-10.1
SYRS
Syros Pharmaceuticals Inc.
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
(for which within five Business Days the Investor determines that a filing under the Hart Scott-Rodino Antitrust Improvements Act of 1976, as amended … required filings under other applicable antitrust laws that the Company or any Investor reasonably determines in good faith to be necessary or appropriate
8-K
EX-10.4
SYRS
Syros Pharmaceuticals Inc.
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
Business Days the Investor determines that a filing under the Hart Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act … other applicable antitrust laws that the Company or any Investor reasonably determines in good faith to be necessary or appropriate to effect
425
4sguuzsgs
5 Jul 22
Business combination disclosure
7:14am
- Prev
- 1
- Next